Japan’s Eisai buys MGI of US for $4bn: Mizuho, JPM close to loan
THE HUNT by Asian companies for cross-border acquisitions continues unabated into the holiday season, as Japanese drugmaker Eisai announced on Monday that it would buy US bio-pharmaceutical firm MGI Pharma for $3.92bn (¥435bn).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts